Literature DB >> 25894096

The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.

Hilda A Crawford1,2, Belinda Barton3,4, Meredith J Wilson5,6, Yemima Berman7,8, Valerie J McKelvey-Martin9, Patrick J Morrison9,10, Kathryn N North11.   

Abstract

The complications of neurofibromatosis type 1 (NF1) are widespread, unpredictable and variable and each person's experience of this disorder is unique. However, few studies have addressed the impact of NF1 from an individual's perspective. This qualitative study aims to identify the ways in which NF1 impacts upon affected Australian adults. Sixty adults with NF1, with a range of disease severity and visibility participated in a semi-structured interview about the ways in which NF1 impacted upon their life and health. Data were analyzed using grounded theory methodology. Results indicated that NF1 impacts upon affected adults in five major ways: 1) cosmetic burden of disease 2) learning difficulties 3) concerns about the risk of passing NF1 to offspring 4) uncertain disease progression, and 5) pain. Participants identified the aspects of NF1 that bothered them the most, creating a hierarchy of NF1 concerns within the cohort. Importantly, mildly affected adults shared many of the same concerns as those more severely affected. This study enhances our current understanding of the impact of NF1 in adulthood, and augments existing recommendations for the care of these patients.

Entities:  

Keywords:  Adults; Cosmetic; Learning difficulties; Lives; Neurofibromatosis 1; Pain; Uncertainty; Wellbeing

Mesh:

Year:  2015        PMID: 25894096     DOI: 10.1007/s10897-015-9829-5

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  51 in total

1.  Influence of learning disabilities on the tumour predisposition syndrome NF1--survey from adult patients' perspective.

Authors:  Sofia Granström; Reinhard E Friedrich; Anna Katharina Langenbruch; Matthias Augustin; Victor-Felix Mautner
Journal:  Anticancer Res       Date:  2014-07       Impact factor: 2.480

2.  What do French patients and geneticists think about prenatal and preimplantation diagnoses in Marfan syndrome?

Authors:  F Coron; T Rousseau; G Jondeau; E Gautier; C Binquet; L Gouya; V Cusin; S Odent; Y Dulac; H Plauchu; P Collignon; M-A Delrue; B Leheup; L Joly; F Huet; J Thevenon; G Mace; C Cassini; C Thauvin-Robinet; J E Wolf; N Hanna; P Sagot; C Boileau; L Faivre
Journal:  Prenat Diagn       Date:  2012-11-13       Impact factor: 3.050

3.  Young adults' experience of living with neurofibromatosis type 1.

Authors:  Grete Hummelvoll; Kjell Magnus Antonsen
Journal:  J Genet Couns       Date:  2012-07-20       Impact factor: 2.537

4.  Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

Authors:  S M Huson; P S Harper; D A Compston
Journal:  Brain       Date:  1988-12       Impact factor: 13.501

5.  The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.

Authors:  Shelley L Hyman; Arthur Shores; Kathryn N North
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

6.  Gender response to neurofibromatosis 1.

Authors:  J Ablon
Journal:  Soc Sci Med       Date:  1996-01       Impact factor: 4.634

7.  Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.

Authors:  Emily C Oates; Jonathan M Payne; Sheryl L Foster; Nigel F Clarke; Kathryn N North
Journal:  Am J Med Genet A       Date:  2013-02-20       Impact factor: 2.802

8.  Neurofibromatosis 1: analysis of the demand for prenatal diagnosis in a French cohort of 361 patients.

Authors:  David Farhi; Sylvie Bastuji-Garin; Kiarash Khosrotehrani; Dominique Vidaud; Christine Bellane; Jean Revuz; Pierre Wolkenstein
Journal:  Am J Med Genet A       Date:  2008-01-15       Impact factor: 2.802

9.  Neurofibromatosis type 1 (NF1): knowledge, experience, and reproductive decisions of affected patients and families.

Authors:  C M Benjamin; A Colley; D Donnai; H Kingston; R Harris; L Kerzin-Storrar
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

Review 10.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

View more
  17 in total

1.  CRMP2-Neurofibromin Interface Drives NF1-related Pain.

Authors:  Aubin Moutal; Li Sun; Xiaofang Yang; Wennan Li; Song Cai; Shizhen Luo; Rajesh Khanna
Journal:  Neuroscience       Date:  2018-04-12       Impact factor: 3.590

2.  Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.

Authors:  Krister W Fjermestad; Livø Nyhus; Øivind J Kanavin; Arvid Heiberg; Lise B Hoxmark
Journal:  J Genet Couns       Date:  2018-02-10       Impact factor: 2.537

3.  Knowledge and Self-Esteem of Individuals with Neurofibromatosis Type 1 (NF1).

Authors:  Kayla Rosnau; S Shahrukh Hashmi; Hope Northrup; John Slopis; Sarah Noblin; Myla Ashfaq
Journal:  J Genet Couns       Date:  2016-11-04       Impact factor: 2.537

4.  Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.

Authors:  Karoline Doser; Line Kenborg; Elisabeth Wreford Andersen; Pernille Envold Bidstrup; Anja Kroyer; Hanne Hove; John Østergaard; Sven Asger Sørensen; Christoffer Johansen; John Mulvihill; Jeanette Falck Winther; Susanne Oksbjerg Dalton
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

Review 5.  Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.

Authors:  Shreya S Bellampalli; Rajesh Khanna
Journal:  Pain       Date:  2019-05       Impact factor: 6.961

6.  Quality of Life in Adults with Neurofibromatosis 1 in Brazil.

Authors:  Natália Parenti Bicudo; Balduíno Ferreira de Menezes Neto; Lucimar Retto da Silva de Avó; Carla Maria Ramos Germano; Débora Gusmão Melo
Journal:  J Genet Couns       Date:  2016-03-05       Impact factor: 2.537

7.  Lifespan Development: Symptoms Experienced by Individuals with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas from Childhood into Adulthood.

Authors:  Sally E Jensen; Zabin S Patel; Robert Listernick; Joel Charrow; Jin-Shei Lai
Journal:  J Clin Psychol Med Settings       Date:  2019-09

8.  The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.

Authors:  Ashley Crook; Rebekah Kwa; Sarah Ephraums; Mathilda Wilding; Lavvina Thiyagarajan; Jane Fleming; Katrina Moore; Yemima Berman
Journal:  Fam Cancer       Date:  2021-05-08       Impact factor: 2.446

9.  CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.

Authors:  Aubin Moutal; Xiaofang Yang; Wennan Li; Kerry B Gilbraith; Shizhen Luo; Song Cai; Liberty François-Moutal; Lindsey A Chew; Seul Ki Yeon; Shreya S Bellampalli; Chaoling Qu; Jennifer Y Xie; Mohab M Ibrahim; May Khanna; Ki Duk Park; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

10.  Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.

Authors:  Sheilagh Maguiness; Yemima Berman; Nathan Rubin; Melissa Dodds; Scott R Plotkin; Claire Wong; Christopher Moertel
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.